Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanisms.

Autor: Stubbs, Brianna J.1 (AUTHOR) bstubbs@buckinstitute.org, Alvarez Azañedo, Gabriela1 (AUTHOR), Peralta, Sawyer1 (AUTHOR), Diaz, Stephanie Roa1 (AUTHOR), Gray, Wyatt1 (AUTHOR), Alexander, Laura1 (AUTHOR), Silverman-Martin, Wendie1 (AUTHOR), Garcia, Thelma Y.1 (AUTHOR), Blonquist, Traci M.2 (AUTHOR), Upadhyay, Vaibhav3,4 (AUTHOR), Turnbaugh, Peter J.3,5 (AUTHOR), Johnson, James B.6 (AUTHOR), Newman, John C.1,7 (AUTHOR) jnewman@buckinstitute.org
Zdroj: PLoS ONE. 9/18/2024, Vol. 19 Issue 9, p1-19. 19p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje